Inspire is not universally better than CPAP. CPAP remains the more effective treatment for reducing breathing interruptions during sleep, and it works for a wider range of patients. But for people who genuinely cannot tolerate CPAP, Inspire offers a meaningful alternative with strong satisfaction rates. In FDA registry data, 91% of patients who switched from CPAP to Inspire said they preferred the implant. The real question isn’t which device is “better” in the abstract, but which one you’ll actually use consistently.
How Each Treatment Works
CPAP keeps your airway open by pushing a steady stream of pressurized air through a mask while you sleep. Think of it as an air splint: the pressure physically prevents your throat from collapsing. It’s effective across nearly all severity levels of obstructive sleep apnea, and when used consistently, it’s considered the gold standard treatment.
Inspire takes a completely different approach. A small device implanted in your chest sends mild electrical pulses to the nerve that controls your tongue (the hypoglossal nerve). Each time you breathe in, the device stimulates your tongue muscles to push forward, opening the airway at multiple levels, including behind the soft palate and around the base of the tongue. The stimulation only fires at the start of each breath to avoid fatiguing the muscle. There’s no mask, no hose, no air pressure. You turn it on with a small remote before bed and turn it off when you wake up.
Effectiveness at Reducing Apnea Events
CPAP, when worn properly, can reduce apnea events to near-zero in most patients. That level of control is hard to beat on paper. The catch is that CPAP only works while it’s on your face, and many people take it off during the night or skip nights entirely.
Inspire reduces apnea events significantly, though typically not as completely as CPAP. In clinical trials, patients saw their average number of breathing interruptions per hour drop from about 43 to about 14. A systematic review of long-term data found the average reduction held steady at 18 fewer events per hour after five years, with a 75% surgical success rate at that point. Daytime sleepiness scores also improved and stayed improved over five years.
The practical gap between the two narrows when you factor in real-world use. A CPAP that sits on the nightstand treats nothing. Inspire, once implanted, is always available. For someone who has genuinely failed CPAP therapy, going from zero effective treatment to a 75% chance of surgical success is a substantial improvement.
Adherence and Daily Use
CPAP adherence is one of the most well-documented problems in sleep medicine. Studies consistently show that a significant portion of CPAP users don’t meet the minimum threshold of four hours per night. Mask discomfort, nasal dryness, claustrophobia, noise, and air leaks all contribute to people abandoning therapy. Some patients try multiple mask styles and pressure settings without finding a tolerable combination.
Inspire sidesteps most of those issues. There’s no mask to fit, no water chamber to fill, no hose to manage. Patients report that not dealing with a mask is the most meaningful quality-of-life improvement. The device requires a brief activation with a bedside remote each night, and that’s essentially it. Battery life in newer models lasts about 11 years before the pulse generator needs replacement.
Travel and Maintenance
CPAP machines require a power source, distilled water for the humidifier, regular cleaning of the mask and tubing, and periodic replacement of filters and cushions. Traveling with CPAP means packing extra equipment and finding outlets, though newer travel-sized machines have made this easier.
Inspire’s maintenance burden is minimal. You carry the small handheld remote, and that’s it. No cleaning, no supplies, no power cord. For frequent travelers, this difference can be significant.
Who Qualifies for Inspire
This is where the comparison shifts dramatically. CPAP can be prescribed to virtually anyone with obstructive sleep apnea, regardless of severity, weight, or age. Inspire has strict eligibility requirements set by the FDA.
To qualify for Inspire, you must:
- Have moderate to severe sleep apnea with 15 to 100 breathing interruptions per hour
- Be unable to use or tolerate CPAP, with documented evidence of trying and failing
- Have a BMI of 40 or below
- Be at least 22 years old (or 18 to 21 under expanded criteria)
- Pass a sleep endoscopy, a procedure where a doctor examines your airway under sedation to check how it collapses
That last requirement is critical. If your airway collapses inward from all sides at once (called complete concentric collapse), Inspire won’t work for you and the procedure is contraindicated. The sleep endoscopy identifies this pattern before surgery. Patients whose airway collapses primarily in a front-to-back direction at any level are generally eligible.
Surgical Risks
CPAP carries no surgical risk. Its side effects are comfort-related: skin irritation from the mask, dry mouth, nasal congestion, bloating from swallowed air, and disrupted sleep for bed partners due to noise.
Inspire requires a surgical procedure under general anesthesia. The implant goes in the chest with leads running to the hypoglossal nerve and a breathing sensor between the ribs. A review of adverse event reports submitted to the FDA found that the most common complications were infection (34% of reported events), temporary nerve weakness (15%), and fluid buildup or bruising at the surgical site (12%). About 42% of reported adverse events required a follow-up surgery, most commonly to remove or reposition the device. It’s worth noting that FDA adverse event databases capture problems, not routine successes, so these percentages reflect the profile of complications when they occur rather than the overall complication rate among all patients. The five-year serious adverse event rate in the original clinical trial was 6.3%.
The implant doesn’t permanently change your airway anatomy. If the device is removed or turned off, your airway returns to its previous state without lasting effects.
Cost and Insurance
CPAP machines typically cost $500 to $3,000 out of pocket, with most insurance plans covering a large portion after a copay. Ongoing costs include replacement masks, filters, and tubing every few months.
Inspire is significantly more expensive upfront. The total cost of surgery, device, and programming can run $30,000 to $40,000 before insurance. Medicare covers Inspire for qualifying patients after a $283 deductible, with 20% coinsurance. Medicare data puts the average patient cost at roughly $1,800 to $5,300 depending on whether the procedure is done at a hospital outpatient department or a surgical center. Additional charges for the surgeon, anesthesiologist, the sleep endoscopy, and follow-up programming visits may apply separately.
Most private insurers now cover Inspire but require documentation that you’ve tried and failed CPAP. Medicare specifically requires that your sleep study was conducted within the past two years and that your doctor has objective evidence of CPAP intolerance. Getting approval often involves submitting records showing how long you tried CPAP and why it didn’t work.
Which One Is Right for You
If you can tolerate CPAP and use it consistently, it remains the more effective and less invasive option. The air pressure control is immediate, adjustable, reversible, and carries no surgical risk. Many people find a comfortable setup after experimenting with different mask styles or switching to an auto-adjusting machine.
Inspire makes the most sense if you’ve genuinely tried CPAP and cannot make it work. Not “I don’t like it” after a week, but a sustained effort with different masks and pressure settings that still leaves you pulling the mask off at 2 a.m. or avoiding it altogether. For those patients, the choice isn’t really Inspire versus CPAP. It’s Inspire versus untreated sleep apnea, and untreated moderate-to-severe sleep apnea carries serious long-term cardiovascular and cognitive risks. In that context, an implant with a 75% success rate at five years is a strong option.